Pancreatic Cancer Research

ResearcherKeio UniversityNo recent work listed

Ayano Kabashima

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-9399-7895; OpenAlex author ID A5041897187. Sources: OpenAlex.

Their work

Papers
3 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
13
Papers, trials and grants by year

2012: 1 paper · 2013: none · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: 1 paper · 2023: 1 paper

Papers 3

  1. Identification of a novel target of SETD1A histone methyltransferase and the clinical significance in pancreatic cancer. Co-author DOI 10.1111/cas.15615↗
  2. cGAS-STING signaling encourages immune cell overcoming of fibroblast barricades in pancreatic cancer. Co-author DOI 10.1038/s41598-022-14297-5↗
  3. Chemoresistance is associated with cancer stem cell-like properties and epithelial-to-mesenchymal transition in pancreatic cancer cells. First author PMID 22993328↗

Closest collaborators

The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Minoru Tanabe · 2 shared papers, 2022–2023 · strength 0.31
  2. Takeshi Ishii · 2 shared papers, 2022–2023 · strength 0.31
  3. Hiroaki Ono · 1 shared paper, 2023 · strength 0.16
  4. Shuichi Watanabe · 1 shared paper, 2023 · strength 0.16
  5. Daisuke Asano · 1 shared paper, 2023 · strength 0.16
  6. Kosuke Ogawa · 1 shared paper, 2023 · strength 0.16
  7. Shinji Tanaka · 1 shared paper, 2023 · strength 0.16
  8. Shinji Tanaka · 1 shared paper, 2022 · strength 0.16
  9. Atsushi Masamune · 1 shared paper, 2022 · strength 0.16
  10. Hiromasa Takaishi · 1 shared paper, 2012 · strength 0.03
  11. Motoko Izumiya · 1 shared paper, 2012 · strength 0.03
  12. Yasuo Hamamoto · 1 shared paper, 2012 · strength 0.03
  13. Toshifumi Hibi∥ · 1 shared paper, 2012 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.